Osimertinib: A third-generation tyrosine kinase inhibitor...

  • Main
  • 2017 / 05
  • Osimertinib: A third-generation tyrosine kinase inhibitor...

Osimertinib: A third-generation tyrosine kinase inhibitor for treatment of epidermal growth factor receptor-mutated non-small cell lung cancer with the acquired Thr790Met mutation

Bollinger, Meredith K, Agnew, Amanda S, Mascara, Gerard P
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Oncology Pharmacy Practice
DOI:
10.1177/1078155217712401
Date:
May, 2017
File:
PDF, 156 KB
english, 2017
Conversion to is in progress
Conversion to is failed